Mackay Shields LLC’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Mackay Shields LLC’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,400	Closed	-$411K	–	150
2023 Q1	$411K	Hold	3,400	–	–	0.01%	135
2022 Q4	$391K	Hold	3,400	–	–	0.01%	152
2022 Q3	$349K	Sell	3,400 -21	-0.6%	-$2.22K	0.01%	155
2022 Q2	$348K	Buy	3,421 +21	+0.6%	+$2.29K	0.01%	158
2022 Q1	$396K	Hold	3,400	–	–	﹤0.01%	651
2021 Q4	$388K	Buy	+3,400	New	+$388K	﹤0.01%	644
2020 Q4	–	Sell	-3,400	Closed	-$379K	–	1620
2020 Q3	$379K	Buy	+3,400	New	+$381K	﹤0.01%	1233

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Mackay Shields LLC's BSX.PRA Position: Q2 2023 in Review

Mackay Shields LLC sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 3,400 shares — an estimated $411K sold.

Mackay Shields LLC first reported a position in BSX.PRA in Q3 2020 and held it in 7 quarters. The position peaked at $411K in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Mackay Shields LLC reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Mackay Shields LLC sold 3,400 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $411K.
Mackay Shields LLC first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q3 2020 and held it in 7 quarters.
Mackay Shields LLC's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $411K in Q1 2023.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Mackay Shields LLC's 13F filing for Q2 2023, filed 27 Jul 2023.